Near term newborn's hyper bilirubinemia. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: In the intervention group babies receive phenobarbital with phototherapy. Phenobarbital with dose (12 mg / kg) administered orally in one dose. Indication of starting and discontinuin
Treatment - Drugs
In the intervention group babies receive phenobarbital with phototherapy. Phenobarbital with dose (12 mg / kg) administered orally in one dose. Indication of starting and discontinuing phototherapy w
Control group give only phototherapy,without phenobarbital
Sponsors
North Khorasan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Days to 7 Days
Inclusion criteria
Inclusion criteria: Term and near-term babies (> 35 week) or (> 2500 g) with serum bilirubin levels in the therapeutic range (> 15 mg / dl) who admitted in hospital without signs of hemolysis, internal bleeding, G6PD, sepsis, severe respiratory illness requiring mechanical ventilation and congenital anomalies are enrolled after parental consent.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin. Timepoint: Weeks 35-42. Method of measurement: Blood sample test.;Hematocrit,coombs,blood group,retic count. Timepoint: at birth time and starting treatment to discharge at hospital. Method of measurement: serum examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Hospitalization period, phototherapy duration. Timepoint: Days of hospitalization, hours of phototherapy. Method of measurement: Medical records. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Ghasem Bayani
North Khorasan University of Medical Sciences
Outcome results
None listed